These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 38403509

  • 21. Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial.
    van Werkhoven CH, Postma DF, Mangen MJ, Oosterheert JJ, Bonten MJ, CAP-START study group.
    BMC Infect Dis; 2017 Jan 10; 17(1):52. PubMed ID: 28068956
    [Abstract] [Full Text] [Related]

  • 22. [Comparison of the combination and quinolone therapy in community acquired pneumonia].
    Kılıç Soylar Ö, Kılınç O, Ellidokuz H.
    Tuberk Toraks; 2015 Sep 10; 63(3):165-9. PubMed ID: 26523897
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The science of selecting antimicrobials for community-acquired pneumonia (CAP).
    File TM.
    J Manag Care Pharm; 2009 Mar 10; 15(2 Suppl):S5-11. PubMed ID: 19236135
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study.
    Kyriazopoulou E, Sinapidis D, Halvatzis S, Velissaris D, Alexiou N, Kosmas V, Adami ME, Kyprianou M, Kyprianou A, Stefos A, Lada M, Koutoukas P, Pavlaki M, Kyriakoudi A, Makina A, Gogos C, Niederman MS, Giamarellos-Bourboulis EJ.
    Int J Antimicrob Agents; 2020 Jan 10; 55(1):105836. PubMed ID: 31704213
    [Abstract] [Full Text] [Related]

  • 30. Beta-lactam versus beta- lactam/macrolide therapy in pediatric outpatient pneumonia.
    Ambroggio L, Test M, Metlay JP, Graf TR, Blosky MA, Macaluso M, Shah SS.
    Pediatr Pulmonol; 2016 May 10; 51(5):541-8. PubMed ID: 26367389
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Diagnosis and management of community-acquired pneumonia in adults.
    Watkins RR, Lemonovich TL.
    Am Fam Physician; 2011 Jun 01; 83(11):1299-306. PubMed ID: 21661712
    [Abstract] [Full Text] [Related]

  • 33. Monotherapy versus Combination Therapy in Patients Hospitalized with Community-Acquired Pneumonia.
    Kolditz M, Halank M, Höffken G.
    Treat Respir Med; 2006 Jun 01; 5(6):371-83. PubMed ID: 17154666
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia.
    Ceccato A, Cilloniz C, Martin-Loeches I, Ranzani OT, Gabarrus A, Bueno L, Garcia-Vidal C, Ferrer M, Niederman MS, Torres A.
    Chest; 2019 Apr 01; 155(4):795-804. PubMed ID: 30471269
    [Abstract] [Full Text] [Related]

  • 38. Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database.
    Lee MG, Lee SH, Chang SS, Chan YL, Pang L, Hsu SM, Lee CC.
    Medicine (Baltimore); 2015 Sep 01; 94(39):e1662. PubMed ID: 26426664
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Usefulness of β-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis of a prospective cohort study.
    Ito A, Ishida T, Tachibana H, Nakanishi Y, Tokioka F, Yamazaki A, Washio Y, Irie H, Otake T.
    J Infect Chemother; 2021 Oct 01; 27(10):1447-1453. PubMed ID: 34147355
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.